Solara Active Pharma Sciences Limited
NSE: SOLARA | Information Technology
Market Fundamentals
Stock Intelligence & News
SOLARA ACTIVE PHARMA SCIENCES Ltd (890202)
Conversion of Partly paid-up Rights Equity Shares into fully paid-up Equity shares in relation to the rights issue by the Company, upon receipt of Call Monies, as applicable.
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange regarding Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in relation to the rights issue by the Company, upon receipt of the Call Monies, as applicable. |SUBJECT: Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options. |SUBJECT: ESOP/ESOS/ESPS
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
SOLARA ACTIVE PHARMA SCIENCES Ltd (890202)
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options
Read Full Analysis →Listing of New Securities of Solara Active Pharma Sciences Limited.
Listing of New Securities of Solara Active Pharma Sciences Limited.
Read Full Analysis →Listing of further issue of Solara Active Pharma Sciences Limited
Listing of further issue of Solara Active Pharma Sciences Limited
Read Full Analysis →Solara Active Pharma Sciences Limited
SOLARA ACTIVE PHARMA SCIENCES LIMITED has informed the Exchange about Transcripts - earnings or quarterly calls |SUBJECT: Analyst/Investor Meet Para A-XBRL
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of Earnings conference call pertaining to financial results of the Company for the quarter ended June 30, 2026 |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange regarding Submission of Machine Readable copy of financial results for the quarter ended June 30, 2026. |SUBJECT: Updates
Read Full Analysis →Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and designated him as Senior Management Personnel (SMP) with effect from August 10, 2026. |SUBJECT: General Updates
Read Full Analysis →Get instant alerts when SOLARA breaks news
Join investors who track Solara Active Pharma Sciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SOLARA?
SOLARA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Solara Active Pharma Sciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SOLARA to your custom watchlist.